Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen

Nature Medicine

Volumn 5, Issue 8, 1999, Pages 900-906

  Newberry, Rodney D ^a   Stenson, William F ^a   Lorenz, Robin G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; EGG WHITE; FOOD ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CELL PROLIFERATION; FOOD ALLERGY; IMMUNE RESPONSE; IMMUNOMODULATION; INTESTINE FUNCTION; LAMINA PROPRIA; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ARACHIDONIC ACID; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; INTESTINE, SMALL; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MICE; MICE, TRANSGENIC; MURAMIDASE; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SPLEEN; SULFONAMIDES;

EID: 0032780043     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/11341     Document Type: Article

References (45)

1. Strober, W. et al. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol. Today 18, 61-64 (1997).
2. Powrie, F. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 3, 171-174 (1995).
3. Hurst, S.D., Sitterding, S.M., Ji, S. & Barrett, T.A. Functional differentiation of T cells in the intestine of T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA 94, 3920-3925 (1997).
4. Schieferdecker, H.L., Ullrich, R., Hirseland, H. & Zeitz, M. T cell differentiation antigens on lymphocytes in the human intestinal lamina propria. J. Immunol. 149, 2816-2822 (1992).
5. Braunstein, J., Qiao, L., Autschbach, F., Schurmann, G. & Meuer, S. T cells of the human intestinal lamina propria are high producers of interleukin-10. Gut 41, 215-220 (1997).
6. Gonnella, P.A. et al. In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice. J. Immunol. 160, 4708-4718 (1998).
7. Sher, A. et al. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol. Rev. 127, 183-204 (1992).
8. Groux, H. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742 (1997).
9. Parronchi, P. et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am. J. Pathol. 150, 823-832 (1997).
10. Nilsen, E.M. et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenteralogy 115, 551-563 (1998).
11. Powrie, F. et al. Inhibition of Th1 responses prevents inflammatory bowel disease in seid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1, 553-562 (1994).
12. Davidson, N.J. et al. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J. Exp. Med. 184, 241-251 (1996).
13. Mombaerts, P. et al. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature 360, 225-231 (1992).
14. Uematsu, Y. et al. In transgenic mice the introduced functional T cell receptor beta gene prevents expression of endogenous beta genes. Cell 52, 831-841 (1988).
15. Ho, W.Y., Cooke, M.P., Goodnow, C.C. & Davis, M.M. Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J. Exp. Med. 179, 1539-1549 (1994).
16. Abbas, A.K., Murphy, K.M. & Sher, A. Functional diversity of helper T lymphocytes. Nature 383, 787-793 (1996).
17. Mombaerts, P. et al. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75, 274-282 (1993).
18. Aabakken, L. & Osnes, M. Non-steroidal anti-inflammatory drug-induced disease in the distal ileum and large bowel. Scand. J. Gostroenterol. Suppl. 163, 48-55 (1989).
19. Bjarnason, I., Hayllar, J., MacPherson, A.J. & Russell, A.S. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 104, 1832-1847 (1993).
20. Kaufmann, H.J. & Taubin, H.L. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann. Intern. Med. 107, 513-516 (1987).
21. Demeure, C.E., Yang, L.P., Desjardins, C., Raynauld, P. & Delespesse, G. Prostaglandin E2 primes naive T cells for the production of anti- inflammatory cytokines. Eur. J. Immunol. 27, 3526-3531 (1997).
22. Betz, M. & Fox, B.S. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146, 108-113 (1991).
23. Snijdewint, F.G., Kalinski, P., Wierenga, E.A., Bos, J.D. & Kapsenberg, M.L. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150, 5321-5329 (1993).
24. Smith, W.L., Garavito, R.M. & DeWitt, D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 271, 33157-33160 (1996).
25. Masferrer, J.L. et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA 91, 3228-3232 (1994).
26. Ellner, J.J. & Spagnuolo, P.J. Suppression of antigen and mitogen induced human T lymphocyte DNA synthesis by bacterial lipopolysaccharide: mediation by monocyte activation and production of prostaglandins. J. Immunol. 123, 2689-2695 (1979).
27. Gutgemann, I., Fahrer, A.M., Altman, J.D., Davis, M.M. & Chien, Y.H. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 8, 667-673 (1998).
28. Snyder, D.S., Beller, D.I. & Unanue, E.R. Prostaglandins modulate macrophage la expression. Nature 299, 163-165 (1982).
29. Wu, C.Y., Wang, K., McDyer, J.F. & Seder, R.A. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 161, 2723-2730 (1998).
30. Kalinski, P., Hilkens, C.M., Snijders, A., Snijdewint, F.G. & Kapsenberg, M.L. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159, 28-35 (1997).
31. van der Pouw Kraan, T.C., Boeije, L.C., Smeenk, R.J., Wijdenes, J. & Aarden, L.A. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med 181, 775-779 (1995).
32. Morham, S.G., Langenbach, R., Mahler, J. & Smithies, O. Characterization of prostaglandin H synthase 2 deficient mice and implications for mechanisms of NSAID action. Adv. Exp. Med. Biol. 407, 131-138 (1997).
33. Murphy, E. et al. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183, 901-913 (1996).
34. Ziegler-Heitbrock, H.W., Frankenberger, M. & Wedel, A. Tolerance to lipopolysaccharide in human blood monocytes. Immunobiology 193, 217-223 (1995).
35. Freudenberg, M.A. & Galanos, C. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect. Immun. 56, 1352-1357 (1988).
36. Yamada, T. et al. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 17, 641-662 (1993).
37. MacDonald, T.T. & Spencer, J. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J. Exp. Med. 167, 1341-1349 (1988).
38. Ferreira, R.C. et al. Changes in the rate of crypt epithelial cell proliferation and mucosal morphology induced by a T-cell-mediated response in human small intestine. Gastroenterology 98, 1255-1263 (1990).
39. Lionetti, P. et al. T-cell activation can induce either mucosal destruction or adaptation in cultured human fetal small intestine. Gastroenterology 105, 373-381 (1993).
40. Langenbach, R. et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83, 483-492 (1995).
41. Morham, S.G. et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83, 473-482 (1995).
42. Futaki, N. et al. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47, 55-59 (1994).
43. Moolenbeek, C. & Ruitenberg, E.J. The "Swiss roll": a simple technique for histological studies of the rodent intestine. Lab. Anim. 15, 57-59 (1981).
44. Cohn, S.M., Schloemann, S., Tessner, T., Seibert, K. & Stenson, W.F. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J. Clin. Invest. 99, 1367-1379 (1997).
45. Kruisbeek, A.M. in Current Protocols in Immunology (eds. Colligan, I.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. & Strober, S.) 3.1.2-3.1.4 (John Wiley and Sons Inc, New York, 1997).